To understand the mechanisms regulating the tissue non-specific alkaline phosphatase (TNAP) activity during development, we characterized c&transcriptional regulatory elements. In embryonic cells and tissues, TNAP expression was driven preferentially by the exon 1A (El A) promoter, one of the two promoters previously defined. Transcriptional activity of ElA promoter was up-regulated by retinoic acid (RA) through a putative RA-responsive element. Transgenic mice analysis with 1ucZ reporter constructs revealed negative regulatory elements within 8.5 kb of ElA promoter. Promoter sequences of endogenous TNAP in non-expressing tissues and those carried by the 8.5 kb-lucZ transgene were found to be highly methylated. A 1 kb fragment of ElA promoter increased the methylation level of 1acZ and promoter sequences. The role of RA and DNA methylation in defining the embryonic expression pattern of TNAP is discussed.
Introduction
Alkaline phosphatases (APs; EC.3.1.3.1.) are ubiquitous membrane-anchored enzymes which catalyze the hydrolysis of monophosphate esters. Although the physiological role of these enzymes is poorly understood, its relevance can be inferred by its ubiquitous distribution and the high level of expression in several cells during vertebrate development, such as primordial germ cells (PGCs) and those in morphogenetic and differentiating centers. An extracellular matrix protein binding domain is present in APs which may be relevant for migratory cells expressing these enzymes (Mill&r and Fishman, 1995) . Of the three isoforms present in the mouse, embryonic (EAP), intestinal (IAP) and tissue non-specific (TNAP) alkaline phosphatases, the latter is expressed in a wide range of tissues and during almost all embryonic development (from the blastocyst stage to birth; Merchant-Larios et al., 1985; Hahnel et al., 1990; MacGregor et al., 1995) . In the mouse, TNAP is located in chromosome 4, and has 12 exons extended in around 50 kb (Terao et al., 1988 . The knockout of this gene had no effect in embryonic development, including PGC migration, although it is lethal a few days after birth (MacGregor et al., 1995) .
One approach to understand the role of TNAP is by studying the c&elements which regulates its gene expression. In general, these elements reside in the noncoding regions, mostly in 5'-flanking sequences, where transcription is activated by specific trans-acting proteins. Two transcripts are found in the adult mouse which derive from different leader exons (exon 1A and exon 1B) and the same coding sequence Studer et al., 1991) . Exon 1A (ElA) and exon 1B (ElB) are located at around 32 kb and 8 kb upstream of the first coding exon (exon 2), respectively (Fig. 3) . EIA promoter is responsible for the expression in several embryonic cell lines and in all adult tissues characterized by relatively high TNAP expression. ElA 5'-flanking region (1.9 kb) 22
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contains a TATA-like box located at -25, three Spl binding sites at positions -61, -71 and -76, several inverted repeats and a perfect direct repeat. Although this fragment could drive moderate expression of a reporter gene in F9 cells , it is unknown if it is capable of driving expression in other cell lines or tissues that express this enzyme. ElB promoter is specifically active in the heart; 800 bp of the presumed ElB promoter is devoid of TATA and CAAT consensus sequences, and contains a 9 bases inverted repeat .
In the present study we characterized the transcription from either ElA or ElB TNAP promoters in a line of embryonic stem (ES) cells, in developing embryos and in transgenic mice bearing reporter constructs. Our results showed that ES cells and embryonic tissues, including PGCs, used ElA promoter to drive the expression of TNAP. Transcriptional activity in ES cells was upregulated by retinoic acid (RA). Accordingly, a 184 bp fragment, containing a putative RA-responsive element (RARE), was able to transfer responsiveness to RA to the thymidine kinase (TK) basal promoter. Most transgenic mice with l&Z reporter constructs, including different fragments of ElA promoter, showed expression in 12.5 days post coitum (d.p.c.) mouse embryos, but reflecting only partially the TNAP expression pattern. Interestingly, all transgenic mice produced, except one, bearing reporter constructs with 8.5 kb of this promoter, showed no expression in any tissue of 12.5 d.p.c. embryos. DNA methylation was considered to be an important inactivating mechanism of TNAP expression as endogenous TNAP methylation was higher in non-expressing than in expressing cells or tissues. In agreement with the presence of DNA methylation-promoting sequences, higher methylation level of ZczcZ and the foremost 1.9 kb of ElA promoter was observed in transgenic mice produced with constructs bearing 8.5 kb than those with shorter fragments. A 1 kb fragment (-5.5 to -4.5) promoted DNA methylation of transgene sequences but there was not an obvious effect in reporter gene expression. We suggest that methylation is a relevant negative regulatory mechanism of TNAP and may explain the expression of this enzyme in germ and tumor cells.
Results

Developing embryos, ES and primordial germ cells use EIA promoter to drive the transcription of TNAP
In order to define the major regulatory elements controlling TNAP expression during development, we first determined which of the two promoters characterized in this gene is used in whole embryos, PGCs and ES cells (Fig. 1) . Reverse transcription-polymerase chain reaction (RT-PCR) specific for transcripts containing either ElA or ElB showed that, in embryos from 8.5 to 12.5 d.p.c., only ElA transcripts were detected. In gonads, where ElA-or ElB-containing TNAP transcripts in embryonic tissues and ES cells. RT-PCRs specific for ElA or ElB were performed and Southern blot hybridization applied to the amplification products using exon-specific oligonucleotides as probes. Autoradiographs for ElA (top; 15 min exposure) or ElB (bottom; O.N. exposure) are shown. RT-PCR products were of the expected sizes (160 bp for El A transcripts, and 188 bp for El B transcripts). RNA samples for RTPCRs were from ES cells, whole embryos (w), the basal region of the allantois (a), the dorsal mesentery (d), gonads (g) and semi-purified primordial germ cells (gc). Positive control tissues (+) were kidney for ElA, and heart for ElB. As negative controls (-), PCR was performed in the absence of template. (B) AP isoforms expressed in ES cells. RTPCRs specific for each isoform were performed. The specific amplification products for the embryonic (E, 438 bp) and the tissue nonspecific (TN, 240 bp) APs were obtained from ES cell RNA. The specific amplification product for the intestinal AP (I, 396 bp) was not detected. The same amount of cDNA was used in this experiment, and verified by performing a RT-PCR for the HPRT constitutive gene (not shown). (C) In situ AP activity in gel in the absence or presence of specific inhibitors. Levamisole (L, an inhibitor of TNAP) or Lphenylalanine (P, an inhibitor of IAP ) were used. Note the reduction in total AP activity (T) in the presence of levamisole.
germ cells are the only histochemical AP-positive cells, and in semi-purified PGCs, El A transcript was also the only transcription product detected. This observation was reiterated in regions containing migratory PGCs (the base of allantois and dorsal mesentery; Fig 1A) . Therefore, ElA promoter of TNAP is, likely, the major promoter used during development.
Because ES cells express high levels of AP, preserve the potential to differentiate in vitro and in vivo to several cell types, and are not derived from tumors (several tumor cell lines overexpress or express ectopically AP), they are good candidates to study AP gene regulatory mechanisms. ES cells are derived from the inner cell mass of the blastocyst and, although it was previously established that the blastocyst expresses EAP and TNAP (Hahnel et al., 1990) it is now known that the latter isoform is expressed in cells of the inner cell mass and of the trophectoderm (MacGregor et al., 1995) . To determine which AP isoform(s) is (are) expressed in ES cells (AB 1 line), RT-PCR for each isoform were performed. We found that EAP and TNAP mRNAs were present but not those of IAP (Fig.  IB) ; based on the amount of the amplified product, it appears that TNAP mRNA level expression was at least twice that of EAP mRNA. Moreover, densitometric analysis of in situ gel AP activity in the presence or absence of levamisole (a specific inhibitor for TNAP; Borgers, 1973) , indicated that around 80% of the total AP activity was derived from the TNAP isoform (Fig. 1C) . Only ElA transcripts were observed in these cells, indicating that the same promoter as in developing embryos is used (Fig. 1A) .
TNAP EIA promoter is regulated by RA in ES cells
It has been reported that AP expression can be upregulated by glucocorticoids, vitamin D, parathyroid and thyroid hormones, estrogens, RA and CAMP in several cell lines (Firestone and Heath, 1981; Scheibe et al., 1991; Heath et al., 1992) . Up-regulation of TNAP expression by RA has been observed in P19 and F9 teratocarcinoma cell lines and by CAMP in the latter Scheibe et al., 1991; Studer et al., 1991) . In order to determine if transcription can be activated in response to these activators in ES cells, we performed specific RT-PCR for either ElA or ElB transcripts. As shown in Fig. 2 Fold increase in P-gal activity with RA scripts was increased by RA. Similarly, the level of TNAP activity was duplicated in the presence of RA (Fig  2) . Increases in either TNAP transcripts or AP activity were not observed when cultured 15 h with dbcAMP, 17-/I-estradiol or T3 thyroid hormone (not shown).
In order to locate the possible RARE, we designed several TNAP ElA promoter-lacZ fusion constructs (Fig.  3A) . ES cells were transiently transfected with these constructs and cultured in the presence or absence of RA. As can be observed in Fig. 3B , in the presence of RA, a significant increase in /Lgalactosidase activity was obtained with constructs containing 5.5 or 8.5 kb of ElA promoter (lo-and 23-fold increase, respectively). This data suggest that TNAP transcription is directly regulated by RA. Transient transfection with 1acZ fusion constructs containing deletions in the region between positions -1.9 and -5.5 of ElA promoter (Fig. 3A) localized the potential RARE in a 1 kb fragment (from -5.5 to -4.5; Fig. 3B ).
In order to more finely identify the potential RARE and establish if it could transfer RA responsiveness to a heterologous promoter, the aforementioned 1 kb fragment was digested with Sau3A and EcoRI and the resulting D, Escalante-Atcalde et al. /Mechanisms ofDevelopment 57 (1996) showed that Fl and Flb fragments were able to transfer RA responsiveness to the TK promoter as a four-and three-fold increase, respectively, in luciferase activity was observed by addition of RA (Fig. 4B ). These data locate the putative RARE within a 184 bp fragment (Flb). Sequence analysis revealed a related DR5 sequence (a/sgs/,tcannnnna/pgp/,tca; Leblanc and Stunnenberg, 1995) within this fragment ( Fig. 5) , proposed as the major element responsible for RA transcriptional
activation. An additional closely related DR5 sequence in the antisense strand of F3 fragment and one DRl in the antisense strand of Fla fragment were found, but they did not confer RA transcriptional activation in our assays.
EIA promoter is negatively regulated in transgenic mice
An approach to define which sequences are controlling the temporal and tissue-specific gene expression is by introducing promoter-reporter gene fusion constructs in transgenic mice. In 12.5 d.p.c. embryos, AP is highly active in intestine, stomach, lung (this report), apical ectodermal ridge of limbs, basal zone of the neural tube, germ cells, genital tubercle and in some pre-ossification centers (limbs and maxilla). TNAP should be the major enzyme responsible of that pattern, since most of the activity detected at 12.5 d.p.c. was dramatically diminished by levamisole (data not shown). In addition, as described above, only ElA-containing transcripts were detected in embryos at different stages, indicating that TNAP expression is driven by ElA promoter during development. Based on this, we generated several stable and transitory transgenic mice with constructs driving 1acZ expression by 1.9,4.3,5.5 or 8.5 kb of ElA upstream sequences. The expression patterns obtained in 12.5 d.p.c. embryos are summarized in Table 1 and some examples shown in Fig.  6 . The B-galactosidase patterns obtained were not identical, but some of the structures stained in many transgenic embryos correlated with those expressing the endogenous TNAP (Merchant-Larios et al., 1985; MacGregor et al., 1995) , such as the stomach and lung epithelia (Tg155 and Tgl l-lOV95) and the apical ectodermal ridge of limbs (Tg20). An intriguing observation was that whereas five out of six (83%) transgenic embryos produced with 1.9 and 4.3 kb fusion constructs showed 1acZ expression, only one out of seven (14%) with 8.5 kb fusion construct had expression. This points to possible negative regulatory elements between -4.3 and -8.5 kb of ElA promoter. Fig. 5 . Sequence analysis of the fragment conferring RA responsiveness and containing a BZ-like repetitive element. The sequence of the fragment from -5.5 (SalI) to -4.5 (BarnHI) was determined (956 bp). The sequence shown it is the region where similarities to the DR5 RARE consensus (bold), and a BZ-like repetitive element (shaded box) sequences were found. Relevant restriction sites are underlined (gtcgac, SaLI; gate, Sau3A; gaattc, EcoRI).
High levels of methylation correlates with the presence of cis-elements within the TNAP EIA promoter
To establish if methylation is a possible mechanism regulating TNAP expression in vivo, we determined the methylation level of the foremost 1.9 kb of ElA promoter in expressing and non-expressing tissues or cell lines. DNA was analyzed by Southern blot hybridization following digestion with HpaII and MspI. The methylation level was estimated by the degree of HpaII digestion within the region probed. DNA from brain and ST0 fibroblasts, not expressing TNAP, showed higher levels of methylation than DNA from placenta and ES cells, which express this enzyme abundantly (Fig. 7) . These data suggest that methylation is involved in the negative regulation of TNAP expression.
Methylation levels of 1acZ were determined in transgenie mice bearing different ElA promoter fragments. As shown in Fig. 8A , HpaII bands of higher molecular weight hybridizing to the 1acZ probe were obtained from placental DNA of transgenic embryos produced with constructs containing the ElA promoter fragment from -5.5 to -4.5 kb (AP/8.5lacZ, AW5.5lacZ, API 5.5A2.61acZ). In general, the high level of methylation associated with this fragment did not correlate with the lack of transgene expression (Table 1) . However, transgenie embryos carrying the 8.5 kb promoter construct, which expressed 1acZ very infrequently, displayed the highest level of methylation.
Remarkably, when the fragment from -5.5 to -4.5 was fused to the foremost 1.9 kb of ElA promoter (AP/5.5A2.61acZ), most embryos expressing 1acZ did it in stomach and lung (Table 1 and that it contains relevant tissuespecific/enhancer elements. A higher level of methylation was also observed within the foremost 1.9 kb of ElA promoter in transgenic mice produced with constructs bearing the -5.5 to -4.5 region (Fig. 8B ). Again, the highest level of methylation was observed in transgenic embryos produced with the 8.5 kb promoter construct. Interestingly, independently of the ability to express the transgene, the methylation pattern, defined by the number and relative intensity of the HpaII digestion bands, was very similar among transgenic mice produced with constructs containing the -5.5 to -4.5 region (AP/5.5lacZ, APf5.5A2.61acZ).
Transgenic mice lacking this region (AP/4.31acZ, APi8.5A1.21acZ) produced also a distinctive methylation pattern.
Sequence analysis around position -5.5 kb revealed the presence of a sequence with high similarity (75-80%) to several B2 repetitive elements described in mice and rats (Fig. 5) . Recently, Hasse and Schulz (1994) showed data suggesting that Bl/BZlike repetitive sequences, from different sources, could increase reporter gene de novo methylation. Therefore, ElA promoter contains cisregulatory elements promoting DNA methylation, one of which may involve a B2-like sequence. were performed using the 1.9 kb most proximal region of ElA promoter. As control, placental DNA plus a plasmid containing the foremost 1.9 kb of ElA promoter (1.5 ng) was digested with HpaIl (lA1.9); the expected fragments were produced and were identical to the ones obtained from MspI digested DNA of transgenic mice. Higher molecular weight HpaII fragments hybridizing to the probe are observed in digested DNAs from brain and ST0 fibroblasts than in those from placenta and ES cells.
PI
Discussion
Transcriptional regulation by multiple promoters is a characteristic of several genes. More than one promoter in a single gene may define temporal and tissue-specific expression patterns, and/or differential regulation under certain circumstances. Of the two promoters described for TNAP, in whole embryos (8.5-12.5 d.p.c.) we only found activity of the one directing ElA transcription. PGCs, during their migratory stages (8.5 d.p.c. basal region of allantois, 10.5 d.p.c. dorsal mesentery) and when arriving at the developing gonad (at 11.5-12.5 d.p.c.), expressed only TNAP isoform from ElA promoter. In addition, it has been shown that ElA promoter is regulated by RA and CAMP . On the other hand, transcripts containing ElB have only been detected in the adult heart. Therefore, ElA promoter defines a broader temporal and tissue-specificity than ElB promoter, and seems to be more sensitive to environmental cues:
TNAP regulation by RA
It has been reported that the most proximal 1.9 kb of ElA promoter can drive gene expression in F9 cells, but the activity reported is only 5% of that reached with the SV40 late T-antigen promoter-enhancer sequences . We have obtained similar results in ES cells with reporter constructs extending up to position -8.5 kb from the transcription start of ElA. However, if the SV40 enhancer was added to these constructs, we observed a several-fold increase in promoter activity (data not shown). These data suggest that either additional enhancer elements are required for efficient TNAP expression, or enhancer elements within the fragment analyzed were inactive. RARE is a potential inactive enhancer in ES cells since, as it was reported previously and we confirmed here, RA increases the level of ElA-containing transcript. Indeed, we found a 184 bp fragment at around position -5.5 kb which was able to confer RA responsiveness to a heterologous promoter, and contains a sequence with similarity to the consensus RARE. These data can be interpreted as TNAP transcriptional regulation mediated by a RA nuclear receptor; however, it will be necessary to demonstrate directly whether the RARE found is functional, especially in the context of TNAP promoter.
The RA responsiveness observed in culture may not be relevant for the in vivo TNAP regulation. However, we noticed that in the developing embryo, some regions potentially producing RA (inferred from the expression pattern of the human ADH3, a retinol dehydrogenase gene; Zgombic-Knigth et al., 1994 ) also show AP activity. Among those regions are the apical ectodermal ridge of the limbs, the ventral zone of the neural tube, the craniofacial region and the eye. Since RA has been involved in pattern formation, morphogenesis and differentiation, TNAP may have a role in those processes. However, since no developmental defects were seen in the TNAP-ITNAP-mice, lacking completely TNAP activity, we cannot discard the possibility of TNAP expression pattern being just a consequence of RA signaling.
Tissue-specific sequences of ElA TNAP promoter
We used transgenic mice to look for tissue-specific regulatory elements. Although the 1acZ expression patterns obtained were not totally reproducible, eight 12.5 d.p.c. transgenic embryos showed expression in the lung and stomach epithelium, where TNAP is normally expressed. The most reasonable conclusion from these data is that sequences responsible for tissue-specific expression (i.e. for lung and stomach) are located within the proximal 1.9 kb of ElA promoter but that efficient specific expression requires additional regulatory elements located within the fragment from -5.5 to -4.5 kb. A sequence (TTGCCAAG) with similarity to the thyroid-and lung-specific enhancer element (Fracis-Lang et al., 1992) was found at position -1470 bp of exon IA TNAP promoter. The transcription factor binding to this element is expressed in the lung, and disruption of its gene affects lung development among other organs (Kinamura et al., 1996) . Although with low penetrance, specific transgene Fig. 8 . DNA methylation of 1acZ reporter and TNAP regulatory sequences. Placental DNAs (2Opg) from tmnsgenic embryos bearing AP/lA1.9lucZ (1.9), APllA4.3lacZ (4.3), AP/lASSlucZ (5.5). APIlA8.5fucZ (8.5), AP/lA8.5A1.21acZ (8.5Al.2) and APllA5.5A2.61acZ (5.5A2.6) transgenes, and a wild type embryo (-) were digested as described in Fig. 7 . Specific probes for 1acZ and foremost 1.9 kb of the promoter were used. The overall differences in band intensities between MspI lanes (bands e-g) is due to the tmnsgene copy number. As control, 5 ng of a lacZ-containing plasmid (Ia&) or a plasmid containing the foremost 1.9 kb of ElA promoter (lAl.9) were mixed with wild-type mouse genomic DNA and digested with HpaII; fragments detected are the ones expected and identical to the ones obtained with MspI. (A) Methylation levels of lucZ. A significant increase in the molecular weight of HpaII fragments (higher methylation) is observed as promoter length augments. Moreover, higher methylation is seen in constructs containing the -5.5 to -4.5 kb fragment (5.5A2.6) than in those lacking it (8581.2). (B) Methylation patterns of the foremost 1.9 kb of EIA promoter. Similar methylation pattern (i.e. number and relative intensity of HpaII bands) is seen in lanes 5.5 and 5.5A2.6 (bands b-e) all derived from DNA of tmnsgenic mice carrying the -5.5 to -4.5 fragment. A distinctive pattern is shown in 4.3 and 8.5Al.2 lanes (bands a-d) which is derived from DNA of transgenic mice lacking that fragment. Also, the methylation pattern seen in 8.5 lane is similar to the one displayed in 8.5Al.2 lanes; however, the level of methylation is higher in the former. Sizes of fragments f and g are 608 and 404 bp, respectively. expression was also found at the apical ectodermal ridge of 12.5 d.p.c. embryos but the regulatory elements controlling this pattern seem to differ from those directing expression to the developing stomach and lung.
We have not detected reporter gene expression in scribed here, although SV40 promoter worked efficiently in PGCs (D.E.-A., unpublished observations). In summary, TNAP expression pattern seems to be defined by independent tissue-specific regulatory elements.
PGCs of any transgenic mice produced. In support of the lack of PGC-specific regulatory elements, specific expression was not observed after transfection of semipurified PGCs with any of the 1acZ fusion constructs de- the participating cis-regulatory elements. Recently, it was reported that Bl/B2-like repetitive sequences from the afetoprotein control region, may function to enhance the de novo DNA methylation in transfected cells (Hasse and Shulz, 1994) . The methylation analysis of the 1ucZ in our transgenic mice is in agreement with a role of the B2 repetitive sequence found in TNAP promoter in promoting DNA methylation, but we cannot discard that other sequences within the 1 kb fragment tested could be responsible instead. Interestingly, not only does the fragment from -5.5 to -4.5 increase the global level of methylation, but also it seems that some sites within the foremost 1.9 kb of EIA promoter are more efficiently methylated. Our data suggest that methylation directed by a cisregulatory element contained in the region from -5.5 to -4.5, probably involving a B2 repetitive sequence, is rather specific and independent of the transcriptional activity (see below) and its position within the promoter region.
As we report here, a high level of methylation seems to be important for TNAP inactivation in non-expressing tissues. Accordingly, transgenic mice with reporter constructs containing 8.5 kb of ElA promoter, showing the highest level of methylation among the transgenic embryos produced, expressed 1acZ very infrequently. However, the methylation level associated with the B2-containing fragment in TNAP promoter seems not to be sufficient for gene inactivation. Therefore, additional negative regulatory elements should be located between positions -8.5 and -5.5 kb of ElA promoter. These negative regulatory elements could also promote DNA methylation, as a higher level of methylation was displayed by 8.5 kb than 5.5 kb of ElA promoter; low stringency Southern blot hybridization did not detect any additional B2-related sequence within the 8.5 exon 1A promoter fragment (data not shown). From our data, we suggest that TNAP expression is being negatively regulated by methylation, affecting either specific regulatory sequences or chromatin structure. Specific DNA methylation (e.g. imprinting: programming gene expression) has to occur as differentiation proceeds from the very earliest stages of development, and demethylation (e.g. erase imprinting: resetting the gene expression program), in germ cells during gametogenesis. Recently, Szabd and Mann (1995) suggested, based on the analysis of biallelic expression of imprinted genes, that germ cells start erasing the imprinting program during their migratory phase (7.5-10.5 d.p.c.) and complete it by gonad colonization (11 S-12.5 d.p.c.). Imprinting by methylation reinitiates at around 15.5 d.p.c. in both sexes (Kafri et al., 1992) . Interestingly, germ cells start to express TNAP at around 7.5 d.p.c. (Ginsburg et al., 1990 ) when demethylation would start, and downregulate it after 15.5 d.p.c. (Donovan et al., 1986 ) when methylation re-initiates. It is possible that TNAP expression pattern in germ cells, rather than being of functional relevance, is the result of the methylation-demethylation process. In agreement with this hypothesis, EG cells derived from 8 d.p.c. PGCs, and ES cells, both expressing high levels of TNAP, have in general, an unmethylated DNA (Labosky et al., 1994; Szabo and Mann, 1994) . Remarkably, the level of DNA methylation is commonly lower in tumor than in normal cells (Gama-Sosa et al., 1983) , and usually many tumor cells express high levels of AP (Millan and Fishman, 1995) . Then, the expression of this enzyme in tumor cells could be a consequence of the transforming phenotype rather than being involved directly in the process of tumorigenesis.
This hypothesis may not apply to all human AP isoforms, but it will be of interest to know which human AP genes are regulated by DNA methylation.
In conclusion, TNAP expression pattern during mouse development could result, at least in part, from RA responsiveness and the degree of DNA methylation in particular cell types. One prediction based in this hypothesis is that TNAP will be up-regulated, or ectopically expressed, in RA-treated embryos or in those with the targeted mutation of the DNA (cytosine-5)-methyltransferase gene (Li et al., 1992) . Importantly, it is also predicted that demethylation regulatory elements should exist as methylated transgenes were not demethylated.
Experimental procedures
Cell culture and transfection assays
ES cells (ABl line) were cultured on a feeder fibroblast layer, following a routine protocol (Ramirez-Solis et al., 1993) . To analyze the regulation of TNAP expression, 5 x lo5 ES cells were cultured on gelatin-coated 35 mm tissue culture dishes during 15 h with Ml5 medium alone or supplemented with 10e6 M all truns-RA, 10d3 M CAMP, 10T3 M dbcAMP, 2 X lo6 M 17-/%estradiol or 10m8 M thyroid hormone. Transfections were done with a modification of the method described by Strauss et al. (1993) . Briefly, 0.8 pmol of each construct plus an unspecific plasmid DNA up to 10,~g were used in each transfection.
The DNA was dissolved in 100~1 of OPTIMEM serum-free medium (BRL) and mixed with 5Opg of LipofectAMINE (BRL) dissolved in 100,~l of the same medium. ES cells (1.6 X 106) were transfected in suspension with this mixture during 4 h in a total volume of 1 ml of OPTIMEM. After this, each transfection was split in two, plated on gelatin-coated 35 mm tissue culture dishes and cultured for 24 h in 2 ml of M-15 medium with or without RA (lo-" M).
Collection of embryos and fractions containing primordial germ cells
CD-l mice were mated and the day of plug observation was referred as 0.5 d.p.c. Embryos at 8.5, 10.5, 11.5 and 12.5 d.p.c. and purified primordial germ cells, were obtained following the protocols described by Hogan et al. (1986) .
RT-PCR for AP mRNAs and specific transcripts derivedfrom
EIA and EIB of TNAP RNA purification, RT and PCRs were carried out following standard protocols. For RT-PCR of TNAP mRNA, two oligonucleotides internal to the coding sequence were designed. The sense oligonucleotide sequence is located in exon 4 (5' CCTTAAGGGCCAGCTACACC 3') and the antisense oligonucleotide sequence in exon 5 (5' AGCGCAGGATGGATGTGACC 3'). The predicted molecular weights of the amplification products are 240 bp for the cDNA and 1244 bp for the genomic DNA. For EAP and IAP, the oligonucleotides used were those described by Hanhel et al. (1990) . The samples were subjected to one hot start cycle (95"C, 3 min) followed by 30 amplification cycles (95°C 1 min.; 55°C 1 min 15 s; 72°C 1 min). For ElA-and ElB-specific transcripts, the antisense downstream oligonucleotide was the same for the amplification of both transcripts and its sequence is contained in exon 2 (5' GGTGTACCCTGAGAITCG-TCC 3'). The sense upstream oligonucleotides were specific for ElA (5' TGCGCTCC'ITAGGGCTGCCG 3') and E 1 B (5' GACATAGGGGACAGGGACCTGT 3'). The samples were subjected to 35 amplification cycles (ElA: 95°C 1 min; 55°C 2 min; 72°C 2 min; and ElB: 95°C 1 min; 53"C, 2 min; 72°C 2 min). After amplification the samples were run in a 3% agarose gel, blotted to nylon membranes and hybridized to 32P-labeled oligonucleotides specific for ElA (5' GTCTGTTCCGGCTCGCG 3') or ElB (5' TCGATCCAGATGCTGAA 3') . When necessary, the amount of cDNA used was normalized by performing a RT-PCR amplification specific for the mRNA of the constitutive hypoxanthine phosphoribosyl transferase (HPRT) gene.
Determination of AP activity
For in situ gel analysis, 5 X lo6 ES cells were tripsinized and resuspended in PBS. After centrifugation at 1500 rpm, the cells were resuspended in 0.5 ml of AP buffer (10 mM Tris, pH 9.5; 0.5 mM MgC12), homogenized and centrifuged for 10 min at 3500 rpm. The supernatant was recentrifuged for 15 min at 12 250 rpm. The pellet was resuspended in 100~1 of AP buffer-l% Triton X-100. H20-saturated butanol (100 ~1) was added and mixed during 30 min. The mixture was centrifuged for 30 min at 14 000 rpm. The lower aqueous phase was recovered and the protein was precipitated with acetone. After 1 h centrifugation at 14 000 rpm, the pellet was resuspended in 50,ul of AP buffer. Semi-purified AP (4~1) was run in triplicate in a denaturing 7.5% acrylamide gel without heating the samples before loading. One gel was incubated in 30 ml of AP buffer with 165 ,ug/ml 5-bromo-4-chloro-3-indoyl-phosphate (BCIP). To test the activity in the presence of inhibitors, gels were incubated as above but 25 mM L-phenylalanine or 1 mM levamisole was added to the AP-incubating media. For spectrophotometric measurement of TNAP activity, 5 X 10ms cells cultured as described before were lysed in 100~1 of AP buffer-l% Triton X-100. Fifty ,ul of the extract and 445 ~1 of AP buffer were added to spectrophotometric cuvettes. Five ,ul of 100 mg/ml p-nitrophenol-phosphate were added to each cuvette mixed and incubated for 30 min at room temperature, and protected from light. The reaction was stopped by the addition of 0.5 ml of 0.25 M EDTA and read at OD,,.
For histochemistry, embryos and dissected organs were fixed in 4% paraformaldehyde in PBS, and AP activity developed by incubation in 25 mM Tris (pH 9.0), 0.15 M NaCl, 4.0 mM MgCl,, 4 mg/ml a-naphtyl phosphate (Boehringer Mannheim), and 20 mg/ml Fast Red TR (Sigma) for 10 min at room temperature.
Reporter gene constructs
1acZ reporter constructs were obtained with different fragments of the 5' flanking region of TNAP ElA promoter (Fig. 3A) . A PstI 1.9 kb fragment from the ALPblu construct described by Terao et al. (1990) , was cloned into the unique Hi&III site of the 1acZ expression vector, pCHll0 (Stratagene), using Hind11 linkers. Since the SV40 promoter in this construct could have unwanted effects on the TNAP transcription, a XbaI-BamHI fragment containing 1.86 kb of the 5' flanking region, 77 bp of the ElA as well as the lacZ, was ligated with a XbaIBamHI fragment from the vector pCAT basic (Promega) carrying the ampicillin resistance gene and a replication origin. This plasmid was named pAP/lAl.9lacZ, which has 1.86 kb of E IA promoter, and was used as the basic construct for the ones described below. To obtain pAP/ lA5.51acZ, a SalI-XbaI 3.5 kb fragment from the TNAP genomic clone 81 ) was subcloned into the SalI-XbaI sites of pAPllA1.9lacZ.
For pAP/ lA8.51acZ construct, a Sal1 3 kb fragment from the genomic clone 81, was cloned, in the correct orientation, into the unique Sal1 site of pAPIlA5.5lacZ; for transgenic mice production, Not1 adaptators were added in the 5' extreme of the promoter (SafI) and in the 3' extreme of the 1acZ (BarnHI). pAPllA8.5A1.2lacZ
was obtained by deleting the 1.2 kb SalI-BamHI fragment to pAP/ lA8.5lacZ-NotI.
Construct pAP/lA4.3lacZ was obtained by subcloning the BamHI fragment from pAP/lA5.5lacZ, which includes 4.3 kb from the TNAP ElA promoter fused to the lacZ, in pKS+ (Stratagene). Constructs with other deletions of the ElA promoter were made in two steps, first subcloning the fragments SalI-partial-BamHI (1.2 kb) and SalI-BamHI (1 .O kb) from PAP/I A5.5facZ in pGEM-1 lZf(+) (Promega). Then, these fragments were subcloned as S&I-X6aI fragments into pAP/lA1.9lacZ. The corresponding constructs were named pAP/ lA5.5A2.41acZ and pAP/lA5.5A2.61acZ, respectively. To the latter, a Not1 adaptator was introduced to the 3' extreme of 1acZ for transgenic mice production. The vector pCHll0 (Pharmacia) was used as a control vector for the constitutive expression of lucZ. For the activation of TK promoter by El A promoter sequences, the 1 kb SalIBamHI fragment mentioned above was digested with SaDA-EcoRI and the resulting fragments were subcloned in the expression vector pTKluc kindly donated by Dr. T. Gulick.
Measurement of &galactosidase and luciferase activity
Transfected cells were lysed with lOO@ of Cell Culture Lysis Reagent (Promega) and frozen at -70°C. figalactosidase activity was measured spectrophotometritally using an assay based in the protocol described by Ausubel et al. (1994) . Briefly, 5-50~1 of the extracts were added up to 1 ml of buffer Z (60 mM Na2HP04* 7H,O; 40 mM NaH2P0,*H,0; 10 mM KCl; 1 mM MgSO,*7H,O; 50 mM 2-mercaptoethanol, pH 7.0). The reaction was started by adding 200~1 of 4 mg/ml chlorophenol red b-D-galactopyranoside (CPRG) (Boehringer Mannheim) as substrate, and incubated at 30°C. The reaction was stopped by adding 0.5 ml of 1 M Na2C0, solution and read at ODsT4. One nmol of the product corresponds to OD574 = 0.044 1. Luciferase activity was measured using the Luciferase Assay System (Promega). Briefly, LO@ of each extract and 100~1 of luciferase assay reagent were mixed and measured in a Monolight 2010 automatic luminometer (Analytical Luminescence Laboratory) for 10 s. The photon count was normalized for pg of protein. Protein was quantified by the standard Bradford protocol (Ausubel et al., 1994) .
Sequence determination
Selected fragments were subcloned in Bluescript KS+ vector (Stratagene). The fragments were sequenced using T3 and T7 primers. Sequencing of the clones was accomplished by the Sanger dideoxy chain termination procedure (Sanger et al., 1977) 
Production of transgenic mice
Stable or transitory transgenic mice were generated by pronuclear microinjection as described by Hogan et al. (1986) . Briefly, the male pronucleus of fertilized eggs from CD-I female mice were microinjected and immediately transferred to CD-l pseudopregnant mice. Six fragments containing ElA promoter sequences fused to lacZ, were used for transgenic mouse production:
NotI-Not1 and S&I-Not1 fragments from pAP/lA8.5lucZ; a BamHIBamHI fragment from pAP/lA5,5lacZ; a X6aI-BumHI fragment from pAP/ 1 A 1.9lacZ, a NotI-Not1 fragment from pAP/l A8.5A1.2lucZ and a SalI-Not1 fragment from pAPllA5.5A2.61acZ. Identification of transgenic animals was done by Southern blot hybridization of genomic DNA from tails or placentas. Embryos at 12.5 d.p.c. were fixed with 4% paraformaldehyde and stained overnight at 30°C for /?-galactosidase in 5 mM potassium ferrocyanide and 5 mM potassium ferricyanide in PBS containing 1 mg/ml X-Gal (Molecular Probes).
Methylation analysis of genomic DNA
High molecular weight DNA (2Opg) was digested overnight with HpaII (methylation sensitive) and MspI at a ten-fold excess. DNA was exhaustively digested with HpaII and performance of the enzyme was determined by mixing wild-type chromosomal DNA with a fragment containing the probe sequence. Fragments were separated on 2% agarose gels and transferred to nylon membranes (Hybond) with 0.4 N NaOH. Hybridization was performed at 42°C in 50% formamide. Probes were labeled with [32P]dCTP using the nick translation priming method (Amersham). The probes to test methylation of 1ucZ and the foremost 1.9 kb of ElA promoter were an EcoRI fragment (3.2 kb) and a XbaI-EcoRI fragment (1.86 kb), respectively, both derived from the pAP/lAl.9lucZ construct.
